Nicolas Danchin

Active 1988–2025

179
Papers
35,195
Citations
95
h-index
173
i10-index

Citations

Citations per year for Nicolas Danchin1982: 1 citations1984: 1 citations1990: 1 citations1991: 2 citations1992: 3 citations1993: 13 citations1994: 18 citations1995: 25 citations1996: 20 citations1997: 26 citations1998: 50 citations1999: 37 citations2000: 40 citations2001: 43 citations2002: 33 citations2003: 31 citations2004: 32 citations2005: 48 citations2006: 48 citations2007: 50 citations2008: 49 citations2009: 100 citations2010: 135 citations2011: 149 citations2012: 197 citations2013: 185 citations2014: 262 citations2015: 306 citations2016: 265 citations2017: 276 citations2018: 281 citations2019: 995 citations2020: 866 citations2021: 923 citations2022: 702 citations2023: 562 citations2024: 914 citations2025: 377 citations2026: 26 citations1983: no citations, so this year is not shown1985–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,494 citing papers, 17.4% of this breakdownUnited Kingdom: 1,151 citing papers, 8% of this breakdownItaly: 951 citing papers, 6.6% of this breakdownFrance: 925 citing papers, 6.4% of this breakdownGermany: 903 citing papers, 6.3% of this breakdownChina: 784 citing papers, 5.4% of this breakdownNetherlands: 574 citing papers, 4% of this breakdownCanada: 556 citing papers, 3.9% of this breakdownSpain: 543 citing papers, 3.8% of this breakdownSweden: 357 citing papers, 2.5% of this breakdownSwitzerland: 350 citing papers, 2.4% of this breakdownAustralia: 326 citing papers, 2.3% of this breakdown
0%17.4%Other 31%

Fields

  • Medicine82.3%
  • Biochemistry, Genetics and Molecular Biology4.4%
  • Engineering3.7%
  • Immunology and Microbiology3.2%
  • Neuroscience1.5%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Other3.7%

Topics

  • Acute Myocardial Infarction Research5.2%
  • Coronary Interventions and Diagnostics3.6%
  • Cardiac Imaging and Diagnostics3.4%
  • Antiplatelet Therapy and Cardiovascular Diseases3.1%
  • Venous Thromboembolism Diagnosis and Management2.7%
  • Infective Endocarditis Diagnosis and Management2.7%
  • Other79.3%

Coauthors

All papers

Open in search
  1. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , А. О. Недошивин, A-S Petronio, Jolien W. Roos‐Hesselink, Lars Wallentin, Uwe Zeymer, Gilbert Habib, Patrizio Lancellotti, B Cosyns, Erwan Donal, Paola Anna Erba, Bernard Iung, Aldo P. Maggioni, Bogdan A. Popescu, B Prendergast, P. Tornos, Maryna Andarala, C Berle, A Brunel-Lebecq, E Fiorucci, C Laroche, V. Missiamenou, Clare Taylor, Nora Nabila Ali Tatar-Chentir, Mouaz H. Al‐Mallah, Meriam Åström Aneq, George Athanassopoulos, Luigi P. Badano, S. Benyoussef, Erick Calderón-Aranda, Nuno Cardim, KL Chan, B Cosyns, Isabel Cruz, Thor Edvardsen, Georg Goliasch, Gilbert Habib, Andreas Hagendorff, Krasimira Hristová, Bernard Iung, Otto Kamp, D-H Kang, William Kong, С.Т. Мацкеплишвили, Marwa Meshaal, M Mirocevic, Aleksandar Nešković, Michal Pazderník, E Plonska-Gosciniak, Bogdan A. Popescu, B Prendergast, Maha Raissouni, Ricardo Ronderos, L E Sade, Anita Sadeghpour, Antonia Sambola, Shantanu P. Sengupta, J Separovic-Hanzevacki, Masami Takeuchi, Edwin S. Tucay, Ana Clara Tude Rodrigues, Andréa Varga, J. Vaskelyte, Kazufumi Yamagata, K Yiangou, H Zaky, Isabel Granada, M Mahia, S Ressi, Francisco Nacinovich, Ana Iribarren and 853 more - European Heart Journal 2019 cited by 867

  2. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Motro, Javed Butler, Tim Friede, Klaus H. Jensen, Stuart Pocock, Ewa A. Jankowska, G. Moisés Azize, Anna Mollar Fernández, GO Zapata, P. García Pacho, Anne‐Marie Glenny, F Ferre Pacora, ML Parody, Joseph de Bono, C Beltrano, Alejandro Hershson, N Vita, Luquez Ha, HG Cestari, H. Fernández, Armando Pérez de Prado, Mario A Berli, Ruben Garcia Duran, Jorge Thierer, Mirta Díez, L. Lobo Marquez, RR Borelli, MÁ Hominal, Marco Metra, Pietro Ameri, Piergiuseppe Agostoni, Alessandra Salvioni, Luciano Fattore, Edoardo Gronda, Stefano Ghio, F Turrini, Mariagrazia Uguccioni, M Di Biase, Massimo Piepoli, Stefano Savonitto, Andrea Mortara, Pierfranco Terrosu, Alessandro Fucili, Giuseppe Boriani, Paolo Midi, Enrico Passamonti, F Cosmi, Peter van der Meer, P. Van Bergen, M van de Wetering, NYY al-Windy, Wilco Tanis, M. F. L. Meijs, RGEJ Groutars, HKS The, Bas Kietselaer, HAM van Kesteren, DPW Beelen, Jan Heymeriks, Ruud van de Wal, Jeroen Schaap, Mireille E. Emans, Paul H. Westendorp, P.R. Nierop, Rian M. Nijmeijer, Olivier C. Manintveld, Maria Dorobanţu, DA Darabantiu, Mihnea Zdrenghea, DM Toader and 110 more - The Lancet 2020 cited by 761

  3. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2013 cited by 546

  4. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 339

  5. Acute Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2017 cited by 525

  6. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hafid Ait‐Oufella - Nature Communications 2021 cited by 193

  7. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Veronica Dean, Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Document Reviewers, Çetin Erol, David Jiménez, Walter Ageno, Stefan Agewall, Riccardo Asteggiano, Rupert Bauersachs, Cecilia Becattini, Henri Bounameaux, Harry R. Büller, Constantinos H. Davos, Christi Deaton, Geert-Jan Geersing, Miguel Ángel Gómez Sánchez, Jeroen Hendriks, Arno W. Hoes, Mustafa Kılıçkap, Viacheslav Mareev, Manuel Monréal, João Morais, Petros Nihoyannopoulos, Bogdan A. Popescu, Olivier Sanchez, Alex C. Spyropoulos - European Heart Journal 2014 cited by 3,146

  8. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina Gotcheva, Juan Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Željko Reiner, Petr Ostadal, Margus Viigimaa, Markku S. Nieminen, Vakhtang Chumburidze, Nikolaus Marx, Nicolas Danchin, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, K. Yusoff, Gabriel Arturo Ramos López, Marco Alings, Sigrun Halvorsen, Roger M. Correa Flores, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H Asita de Silva, Emil Hagström, Ulf Landmesser, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Robert A. Vogel and 1,603 more - The Lancet Diabetes & Endocrinology 2019 cited by 328

  9. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA 2021 cited by 287

  10. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Document Reviewers, Guy De Backer, Per Anton Sirnes, Eduardo Alegría Ezquerra, Angelo Avogaro, Lina Badimón, Е. И. Баранова, Helmut Baumgartner, John Betteridge, Antonio Ceriello, Robert Fagard, Christian Funck‐Brentano, Dietrich C. Gulba, David Hasdai, Arno W. Hoes, John Kjekshus, Juhani Knuuti, Philippe Kolh, Eli Lev, Christian Mueller, Ludwig Neyses, Peter M. Nilsson, Joep Perk, Piotr Ponikowski, Željko Reiner, Naveed Sattar, Volker Schächinger, André Scheen, Henrik Schirmer, Anna Strömberg, Svetlana Sudzhaeva, Juan Tamargo - European Heart Journal 2013 cited by 1,958

  11. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Diaz, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lopes, Nina Gotcheva, Shaun G. Goodman, Juan-Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ošťádal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung-Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang-Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M. Correa Flores, Rody G. Sy, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen D. Ristic, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Matthew T. Roe, Robert A. Vogel, Bernard Chaitman and 1,652 more - Journal of the American College of Cardiology 2021 cited by 141

  12. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Díaz, Philip E Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina N Gotcheva, Shaun G. Goodman, Juan Carlos Prieto, Huo Yong, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ostadal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos, Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo-Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M Correa Flores, Rody G. Sy, Andrzej Budaj, João Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Ján Murín, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty and 1,635 more - Circulation 2022 cited by 122

  13. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score

    Authors: , , , , , , , , , , - BMJ Open 2014 cited by 427

  14. Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2010 cited by 1,127

  15. Resting Heart Rate in Cardiovascular Disease

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2007 cited by 1,063

  16. A Pre-Hospital Extracorporeal Cardio Pulmonary Resuscitation (ECPR) strategy for treatment of refractory out hospital cardiac arrest: An observational study and propensity analysis

    Authors: , , , , , , , , , , , , , , , , , - Resuscitation 2017 cited by 374

  17. Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction

    Authors: , , , , , , , , , , , , , - European Journal of Heart Failure 2020 cited by 151

  18. Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2015 cited by 132

  19. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Henry Hess, Ziad Mallat, Pascal Schneider, Christoph J. Binder - Nature 2021 cited by 64

  20. β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 226

  21. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

    Authors: , , , , , , , , , , , , , , , , - BMJ 2016 cited by 185

  22. Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel

    Authors: , , , , , , , - JACC: Cardiovascular Interventions 2020 cited by 163

  23. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , U. Sechtem, Per Anton Sirnes, Michał Tendera, P. Vardas, Petr Widimský, Document Reviewers, A. Vahanian, Río Aguilar, Maria Grazia Bongiorni, Michael A. Borger, Eric G. Butchart, Nicolas Danchin, François Delahaye, R. Erbel, Damian Franzen, K. Gould, R. Hall, Christian Hassager, Keld Kjeldsen, Richard J. McManus, José M. Miró, Aleš Mokráček, Raphaël Rosenhek, J. A. San Roman Calvar, Petar Seferovic, Christine Selton‐Suty, M. S. Uva, Rita Trinchero, Guy Van Camp - European Heart Journal 2009 cited by 2,022

  24. TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , - Circulation Research 2015 cited by 155